Revelation Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$120,254 over the previous period. Total operating expenses were $8,656,664.
Profit Margin
| 2019 | 0 | -3.63K | |
|---|---|---|---|
| 2020 | 0 | -1.63M | |
| 2021 | 0 | -11.98M | |
| 2022 | 0 | -10.79M | |
| 2023 | 0 | -120.25K |
REVBU Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 25.04K | 40.00K | 69.16K | 0 | 0 |
Gross profit | -25.04K | -40.00K | -69.16K | 0 | 0 |
Operating exp. | |||||
Research and development | 4.14M | 5.37M | 6.91M | 2.56M | 0 |
Selling and marketing | 0 | 0 | 0 | 144.25K | 0 |
Total operating expenses | 8.65M | 10.86M | 11.95M | 145.49K | 3.63K |
Operating income | -8.65M | -10.86M | -11.95M | -145.49K | -3.64K |
Other income (expenses), net | 8.53M | 34.96K | -36.35K | -1.48M | 2 |
Income before tax | -120.25K | -10.82M | -11.98M | -1.63M | -3.63K |
Income tax expense | 0 | -34.96K | 0 | -3.79K | 0 |
Net income | -120.25K | -10.79M | -11.98M | -1.63M | -3.63K |
Earnings per share | |||||
Basic EPS | -0.53 | -600.77 | -1.27K | -188.18 | -0.42 |
Diluted EPS | -0.53 | -600.77 | -1.27K | -188.18 | -0.42 |
| Data source | Data source | Data source | Data source |